TROMSOPOROSIS: SECONDARY FRACTURE PREVENTION PROGRAM RESULTED IN HIGH ADHERENCE TO ANTI-OSTEOPOROTIC DRUGS IN TROMSO, NORWAY

被引：0
|
作者：
Andreasen, C. [1 ]
Rogli, V. G. [2 ]
Elvenes, J. [1 ]
Joakimsen, R. M. [1 ]
Borgen, T. T. [3 ]
Solberg, L. B. [4 ]
Frihagen, F. [4 ]
Nordsletten, L. [4 ]
Eriksen, E. F. [4 ]
Basso, T. [5 ]
Dahl, C. [6 ]
Omsland, T. K. [6 ]
Bjornerem, A. [1 ]
机构：
[1] Univ Hosp North Norway, Tromso, Norway
[2] Arctic Univ Norway, Tromso, Norway
[3] Hosp Drammen, Vestre Viken Hosp Trust, Drammen, Norway
[4] Oslo Univ Hosp, Oslo, Norway
[5] St Olavs Univ Hosp, Trondheim, Norway
[6] Univ Oslo, Oslo, Norway
来源：
OSTEOPOROSIS INTERNATIONAL | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P849
引用
收藏
页码：S429 / S430
页数：2
相关论文
共 35 条
  • [21] Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates
    Ojeda-Bruno, S.
    Naranjo, A.
    Francisco-Hernandez, F.
    Erausquin, C.
    Rua-Figueroa, I.
    Quevedo, J. C.
    Rodriguez-Lozano, C.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1821 - 1828
  • [22] Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates
    S. Ojeda-Bruno
    A. Naranjo
    F. Francisco-Hernández
    C. Erausquin
    I. Rúa-Figueroa
    J. C. Quevedo
    C. Rodríguez-Lozano
    Osteoporosis International, 2011, 22 : 1821 - 1828
  • [23] UTILISATION OF ANTI-OSTEOPOROTIC DRUGS IN REAL-WORLD DATA: AN ANALYSIS OF PERSISTENCE TO THERAPY AND RISK OF FRACTURE
    Orlando, V.
    Monetti, V. M.
    Guerriero, F.
    Moretti, A.
    Russo, V.
    Piscitelli, A.
    Iolascon, G.
    Menditto, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 446 - 446
  • [24] DIFFERENT PROFILE OF RISK OF FRACTURE IN PATIENTS TREATED WITH ANTI-OSTEOPOROTIC DRUGS IN ITALY USING A NEW ALGORITHM
    Adami, G.
    Fassio, A.
    Giollo, A.
    Orsolini, G.
    Viapiana, O.
    Gatti, D.
    Rossini, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1179 - 1179
  • [25] Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis
    Saito, T.
    Sterbenz, J. M.
    Malay, S.
    Zhong, L.
    MacEachern, M. P.
    Chung, K. C.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (12) : 3289 - 3300
  • [26] Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis
    T. Saito
    J. M. Sterbenz
    S. Malay
    L. Zhong
    M. P. MacEachern
    K. C. Chung
    Osteoporosis International, 2017, 28 : 3289 - 3300
  • [27] Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma centre secondary prevention project
    Morell, Sabrina
    Hemmeler, Christoph
    Amsler, Felix
    Gross, Thomas
    SWISS MEDICAL WEEKLY, 2017, 147
  • [28] Post-Fracture Prescribed Calcium and Vitamin D Supplements Alone or, in Females, with Concomitant Anti-Osteoporotic Drugs is Associated with Lower Mortality in Elderly Hip Fracture Patients A Prospective Analysis
    Nurmi-Luthje, Ilona
    Luthje, Peter
    Kaukonen, Juha-Pekka
    Kataja, Matti
    Kuurne, Salla
    Naboulsi, Helena
    Karjalainen, Kalevi
    DRUGS & AGING, 2009, 26 (05) : 409 - 421
  • [29] Post-Fracture Prescribed Calcium and Vitamin D Supplements Alone or, in Females, with Concomitant Anti-Osteoporotic Drugs is Associated with Lower Mortality in Elderly Hip Fracture PatientsA Prospective Analysis
    Ilona Nurmi-Lüthje
    Peter Lüthje
    Juha-Pekka Kaukonen
    Matti Kataja
    Salla Kuurne
    Helena Naboulsi
    Kalevi Karjalainen
    Drugs & Aging, 2009, 26 : 409 - 421
  • [30] Comparison of prescribing and adherence patterns of anti-osteoporotic medications post admission for fragility type fracture to an urban teaching hospital and a rural teaching hospital between 2005-2020
    McGowan, B.
    Bennett, K.
    Doherty, J. G.
    Rooney, B.
    McPartland, A.
    Casey, M.
    Silke, C.
    Whelan, B.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S95 - S95
1234